Global Biologics Market was valued at US$ 254.9 Bn in 2017, and expected to reach US$ 580.5 Bn by 2026 at a CAGR of 9.5 % during the forecast period from 2018 to 2026. The growth attributed is due to incessant expansion in product portfolio with increasing demand for biologics across the globe. Rising prevalence of chronic diseases, unremitting research and development activities and continuous investment in biologics contribute to the overall market growth.
Join us at the Protein Drugs and Combination Products Symposium to discuss the latest advances in the biologics field !
Curated by the leading minds across the biologics community, the event aims to share the insights and discussions on real life research, techniques, future perspectives, opportunities, and challenges in Protein Drugs and Combination Products development.
Time: July 25, 2019 (Thursday)
Venue: CTBC Financial Park, 3F, Building A
Registration: registration
|
Ballroom B |
||
|---|---|---|
|
14:00 – 14:05 |
Opening Remarks |
|
|
14:05 – 14:30 |
||
|
14:30 – 14:55 |
||
|
14:55 – 15:20 |
||
|
15:20 – 15:35 |
Break |
|
|
15:35– 16:00 |
Self Injection Technology for Biotech Product |
|
|
16:00 – 16:25 |
Advanced Platform Technologies for Biotherapeutics Development |
|
|
16:25 – 16:50 |
Patent Considerations for Protein Drugs and Combination Products |
|
|
16:50 – 17:30 |
Panel Discussion |
|
※The organizer reserves the right to change the event